Brief: Prostatype Genomics Says Co Enters German Market
13/10/2021 17:03
Oct 13 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* PROSTATYPE GENOMICS ENTERS GERMAN MARKET
* KARLHEINZ DEWALD WILL REPRESENT COMPANY AND PROSTATYPE
PROSTATE
CANCER TEST ON GERMAN MARKET
Source text for Eikon: ID:nWkr2vrZK6
Further company coverage: PROGEN.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue